In CRC, activation of the Wnt/β-catenin pathway and mutations in KRAS and TP53 may elevate the basal NF-κB signaling tone, thereby amplifying the effect of ABLIM1-mediated IκBα degradation (12, 13). The gene discussed is ABLIM1; the disease is colorectal carcinoma.